Grace Therapeutics, Inc. Marketable Securities (Current)
Grace Therapeutics, Inc. (GRCE) had Marketable Securities (Current) of $9.79 million as of 2021-03-31, per its 10-K filed 2021-06-22.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2021-06-22
- 2021-03-31: Marketable Securities, Current $9.79M.
- 2019-03-31: Marketable Securities, Current $8.89M.
| Period end | Marketable Securities, Current |
|---|---|
| 2021-03-31 | $9.79M 10-K · filed 2021-06-22 |
| 2019-03-31 | $8.89M 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |